Matching slides 24,547
Current window 16,531-16,560
Pages 819
Rows per page 30
Slide function: Present Solutionclear collectionreset all

Slide function

16,531-16,560 of 24,547

filter-aware
39
Uses a Venn diagram to illustrate overlap between peripheral blood and tumour gene expression data.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
43
The slide outlines a workflow from experimental data collection to AI-driven design and final compound nomination.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
46
Exscientia | Investor Presentation Deck | 69 slidesExscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
47
Includes two scientific citations for the mechanism and brain penetration.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
48
The slide uses a three-column layout to define the technical requirements for a drug candidate.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
50
The slide uses a linear process flow to explain a complex computational chemistry workflow.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
51
The chart uses a Pareto front to illustrate the trade-off between CNS score and Potency, highlighting that the 'best' molecules are not always the most information-rich.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
53
The slide uses two distinct chart types (dot plot and line chart) to demonstrate safety profiles.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
54
The chart shows tumour volume over time for various dosing regimens compared to a vehicle control.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
55
Exscientia | Investor Presentation Deck | 69 slidesExscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
58
The slide uses a three-column layout to summarize the value proposition of the drug candidate.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
60
Exscientia | Investor Presentation Deck | 69 slidesExscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
61
Exscientia | Investor Presentation Deck | 69 slidesExscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
63
The slide outlines a multi-stage pipeline: Initiate, Analyse, Evolve, 2D Models, 3D Models, and Active Learning.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
64
The image shows a protein binding site with color-coded regions (Donor, Apolar, Acceptor) indicating chemical properties.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
66
The chart shows tumour volume over time (D20-D30). The combination arm (teal) shows a flat line compared to the growth seen in monotherapy and vehicle arms.Exscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
67
Exscientia | Investor Presentation Deck | 69 slidesExscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
09
Includes a map of US regions and a categorized list of service offerings.First Citizens BancShares | Results Presentation Deck | 56 slides · First Citizens BancShares
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
10
The slide uses a matrix structure to categorize technology initiatives into 'Existing Strong Foundation' and 'Recent Enhancements Made/Planned' across two pillars: efficiency and client experience.First Foundation | Investor Presentation Deck | 47 slides · First Foundation
Pitch deck Investor relations Beat · Solution1 hit
27
The slide highlights a fee-only model, organic growth, and specific profit margins.First Foundation | Investor Presentation Deck | 47 slides · First Foundation
Pitch deck Investor relations 1 hit
06
First Merchants | Investor Presentation Deck | 31 slidesFirst Merchants | Investor Presentation Deck | 31 slides · First Merchants Corporation
Pitch deck Investor relations Beat · Business ModelLoop · Logic Chain1 hit
10
The slide outlines a cross-selling strategy where local profit centers collaborate with product experts.First Western Financial | Investor Presentation Deck | 50 slides · First Western Financial
Pitch deck Investor relations Beat · Solution1 hit
21
Includes visual evidence of mobile app interfaces showing cross-product integration.Flutter | Investor Presentation Deck | 28 slides · Flutter Entertainment
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
22
The slide uses a combination of product feature highlights and quantitative performance metrics to demonstrate the value of the Flutter Edge integration.Flutter | Investor Presentation Deck | 28 slides · Flutter Entertainment
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
04
The slide uses a three-column layout to highlight key value propositions of the Olvi-Vec technology.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
06
Uses a process diagram to illustrate the transition from cold to hot tumor states via viral infection.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
07
The central diagram shows a biological mechanism comparing 'Absence of Effector T Cells' (Platinum resistant) vs 'Presence of Effector T Cells' (Platinum sensitive).Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
10
The slide uses a pyramid diagram to represent the evolution of oncolytic virus technology, with Genelux's platform at the top.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
23
The slide highlights a combination therapy approach involving oncolytic immunotherapy and adoptive cell therapy.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
25
The slide highlights physical assets and operational capacity.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit